Literature DB >> 17006602

The effect of taurine on renal ischemia/reperfusion injury.

G Guz1, E Oz, N Lortlar, N N Ulusu, N Nurlu, B Demirogullari, S Omeroglu, S Sert, C Karasu.   

Abstract

Ischemia-reperfusion (I/R) injury is one of the most common causes of renal dysfunction. Taurine is an endogenous antioxidant and a membrane-stabilizing, intracellular, free beta-amino acid. It has been demonstrated to have protective effects against I/R injuries to tissues other than kidney. The aim of this study was to determine whether taurine has a beneficial role in renal I/R injury. Forty Wistar-Albino rats were allocated into four groups as follows: sham, taurine, I/R, and I/R+taurine. Taurine 7.5 mg/kg was given intra-peritoneally to rats in the groups taurine and I/R+taurine. Renal I/R was achieved by occluding the renal arteries bilaterally for 40 min, followed by 6 h of reperfusion. Immediately thereafter, blood was drawn and tissue samples were harvested to measure 1) serum levels of BUN and creatinine; 2) serum and/or tissue levels of malondialdehyde (MDA), glutathione (GSH), glucose 6-phosphate dehydrogenase (G-6PD), 6-phosphogluconate dehydrogenase (6-PGD) and glutathione reductase (GSH-red); 3) renal morphology; and 4) immunohistochemical staining for P-selectin. Taurine administration reduced I/R-induced increases in serum BUN and creatinine, and serum and tissue MDA levels (p<0.05). Additionally, taurine lessened the reductions in serum and tissue glutathione levels secondary to I/R (p<0.05). Taurine also attenuated histopathologic evidence of renal injury, and reduced I/R-induced P-selectin immunoreactivity (p<0.05). Overall, then, taurine administration appears to reduce the injurious effects of I/R on kidney.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17006602     DOI: 10.1007/s00726-006-0383-1

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  9 in total

1.  Radiation protection following nuclear power accidents: a survey of putative mechanisms involved in the radioprotective actions of taurine during and after radiation exposure.

Authors:  Olav Albert Christophersen
Journal:  Microb Ecol Health Dis       Date:  2012-02-01

2.  The efficiency of proanthocyanidin in an experimental pulmonary fibrosis model: comparison with taurine.

Authors:  Yetkin Agackiran; Husamettin Gul; Ersin Gunay; Nalan Akyurek; Leyla Memis; Sibel Gunay; Yusuf Sinan Sirin; Tayfun Ide
Journal:  Inflammation       Date:  2012-08       Impact factor: 4.092

3.  A Combined Treatment with Taurine and Intra-arterial Thrombolysis in an Embolic Model of Stroke in Rats: Increased Neuroprotective Efficacy and Extended Therapeutic Time Window.

Authors:  Weihua Guan; Yumei Zhao; Chao Xu
Journal:  Transl Stroke Res       Date:  2010-11-16       Impact factor: 6.829

4.  Taurine protects against lung damage following limb ischemia reperfusion in the rat by attenuating endoplasmic reticulum stress-induced apoptosis.

Authors:  Xiuli Men; Shuying Han; Junling Gao; Guofu Cao; Lianyuan Zhang; Hong Yu; Hua Lu; Jianyi Pu
Journal:  Acta Orthop       Date:  2010-04       Impact factor: 3.717

5.  Differential effects of taurine treatment and taurine deficiency on the outcome of renal ischemia reperfusion injury.

Authors:  Mahmood S Mozaffari; Rafik Abdelsayed; Champa Patel; Hereward Wimborne; Jun Yao Liu; Stephen W Schaffer
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

Review 6.  Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review.

Authors:  Prabal K Chatterjee
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-09-22       Impact factor: 3.000

7.  Transgenic expression of nonclassically secreted FGF suppresses kidney repair.

Authors:  Aleksandr Kirov; Maria Duarte; Justin Guay; Michele Karolak; Cong Yan; Leif Oxburgh; Igor Prudovsky
Journal:  PLoS One       Date:  2012-05-14       Impact factor: 3.240

8.  Metabolic consequences of cystinuria.

Authors:  Lauren E Woodard; Richard C Welch; Ruth Ann Veach; Thomas M Beckermann; Feng Sha; Edward J Weinman; Talat Alp Ikizler; Jay A Tischfield; Amrik Sahota; Matthew H Wilson
Journal:  BMC Nephrol       Date:  2019-06-20       Impact factor: 2.388

Review 9.  Versatile Triad Alliance: Bile Acid, Taurine and Microbiota.

Authors:  Kalina Duszka
Journal:  Cells       Date:  2022-07-29       Impact factor: 7.666

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.